Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Other Operating Expenses came in at -$32.0 million in Q1 2026, down 113.33% year-on-year from $240.0 million in Q1 2025, and up 50.77% quarter-over-quarter from -$65.0 million in Q4 2025.
Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Other Operating Expenses across 18 years of filings, most recently posting -$32.0 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$32.0 million, down 113.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$159.0 million (up 39.31% YoY), and the FY2025 annual result was -$142.0 million, up 42.51% from the prior year.
- Other Operating Expenses came in at -$32.0 million for Q1 2026 at Bausch Health Companies, up from -$65.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $83.0 million in Q2 2023 to a low of -$225.0 million in Q3 2024.
- The 5-year median for Other Operating Expenses is -$23.0 million (2023), against an average of -$32.3 million.
- Peak annual rise in Other Operating Expenses reached 190.0% in 2025, while the deepest fall reached 3150.0% in 2025.
- Bausch Health Companies' Other Operating Expenses stood at -$29.0 million in 2022, then advanced by 3.45% to -$28.0 million in 2023, then soared by 92.86% to -$2.0 million in 2024, then plunged by 3150.0% to -$65.0 million in 2025, then soared by 50.77% to -$32.0 million in 2026.
- The last three Other Operating Expenses figures came in at -$32.0 million (Q1 2026), -$65.0 million (Q4 2025), and -$80.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.00 Mn |
| Dec 31, 2025 | -65.00 Mn |
| Sep 30, 2025 | -80.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | -15.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -225.00 Mn |
| Jun 30, 2024 | -20.00 Mn |
| Dec 31, 2023 | -28.00 Mn |
| Sep 30, 2023 | -60.00 Mn |
| Jun 30, 2023 | 83.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -29.00 Mn |
| Sep 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -2.00 Mn |
| Dec 31, 2021 | -44.00 Mn |
| Sep 30, 2021 | 183.00 Mn |
| Jun 30, 2021 | -542.00 Mn |
| Mar 31, 2021 | 30.00 Mn |
| Dec 31, 2020 | -330.00 Mn |